Open access
1,697
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
Prasad S. Kulkarnia Serum Institute of India Pvt Ltd, Pune, IndiaCorrespondence[email protected]
View further author information
, View further author information
Chandrasekaran Padmapriyadarsinib Indian Council of Medical Research, Delhi, IndiaView further author information
, Johan Vekemansc Formerly of: Clinical Development, Infection, Late-stage Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SwedenView further author information
, Ashish Bavdekard KEM Hospital Research Centre, Pune, IndiaView further author information
, Madhu Guptae Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education & Research, Chandigarh, IndiaView further author information
, Praveen Kulkarnif Department of Community Medicine, JSS Academy of Higher Education and Research, Mysore, IndiaView further author information
, B.S. Gargg Department of Community Medicine and Dr Sushila Nayar School of Public Health, Mahatma Gandhi Institute of Medical Sciences, Wardha, IndiaView further author information
, Nithya J. Gogtayh Department of Clinical Pharmacology, Seth G S Medical College & KEM Hospital, Mumbai, IndiaView further author information
, Muralidhar Tambei Department of Community Medicine, B J Government Medical College and Sassoon General Hospitals, Pune, IndiaView further author information
, Sanjay Lalwanij Department of Pediatrics, Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, IndiaView further author information
, Kiranjit Singhk Jehangir Clinical Development Centre Pvt Ltd, Pune, IndiaView further author information
, Renuka Munshil Department of Clinical Pharmacology, TN Medical College & BYL Nair Hospital, Mumbai, IndiaView further author information
, Sushant Meshramm Department of Pulmonary Medicine, Government Medical College, Nagpur, IndiaView further author information
, T.S. Selvavinayagamn Directorate of Public Health and Preventive Medicine, Chennai, IndiaView further author information
, Krishna Pandeyo Rajendra Memorial Research Institute of Medical Sciences, Patna, IndiaView further author information
, Devi Madhavi Bhimarasettyp Department of Community Medicine, Andhra Medical College, Visakhapatnam, IndiaView further author information
, S.R. Ramakrishnanq Department of Clinical Research, Sri Ramchandra Institute of Higher Education and Research, Chennai, IndiaView further author information
, Chetanraj Bhamarea Serum Institute of India Pvt Ltd, Pune, IndiaView further author information
, Abhijeet Dharmadhikaria Serum Institute of India Pvt Ltd, Pune, IndiaView further author information
, Chandrashekhar Budhawantr Biostatistics, PPD India Pvt Ltd, Mumbai, IndiaView further author information
, Cyrille J. Bonhommes Laboratory Services, Vaccines Sciences Lab, Clinical Research, PPD, Part of Thermo Fisher Scientific, Richmond, VA, USAView further author information
, Madhuri Thakarb Indian Council of Medical Research, Delhi, IndiaView further author information
, Swarali N. Kurleb Indian Council of Medical Research, Delhi, IndiaView further author information
, Elizabeth J. Kellyt Formerly of: Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
, Manish Gautama Serum Institute of India Pvt Ltd, Pune, IndiaView further author information
, Nivedita Guptab Indian Council of Medical Research, Delhi, IndiaView further author information
, Samiran Pandab Indian Council of Medical Research, Delhi, IndiaView further author information
, Balram Bhargavab Indian Council of Medical Research, Delhi, IndiaView further author information
, Cyrus S. Poonawallaa Serum Institute of India Pvt Ltd, Pune, IndiaView further author information
, Umesh Shaligrama Serum Institute of India Pvt Ltd, Pune, IndiaView further author information
, Dhananjay Kapsea Serum Institute of India Pvt Ltd, Pune, IndiaView further author information
, Bhagwat Gunalea Serum Institute of India Pvt Ltd, Pune, IndiaView further author information
& COVISHIELD Study Group show all, , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Article: 2304974
|
Received 24 Aug 2023, Accepted 10 Jan 2024, Published online: 21 Mar 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.